SCHEMBL7108271

SCHEMBL7108271

CCCCCCCCCCCCCCCCCCNCCOP(=O)(O)O

nearest known ligand 0.66

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LPAR3 Q9UBY5 5/20 0.66
LPAR1 Q92633 4/20 0.66
LPAR2 Q9HBW0 4/20 0.66
S1PR2 O95136 8/20 0.59
S1PR1 P21453 8/20 0.59
S1PR3 Q99500 8/20 0.59
S1PR4 O95977 5/20 0.59
S1PR5 Q9H228 2/20 0.59
ENPP2 Q13822 1/20 0.52
ANPEP P15144 1/20 0.49
ERAP2 Q6P179 1/20 0.49
ALDH1A1 P00352 1/20 0.48
TSHR P16473 1/20 0.48
LPAR5 Q9H1C0 1/20 0.46
SAT1 P21673 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9320338 1.00 LPAR3 (0.66) LPAR3LPAR1LPAR2S1PR2S1PR1
SCHEMBL27788145 1.00 LPAR3 (0.66) LPAR3LPAR1LPAR2S1PR2S1PR1
SCHEMBL5978775 0.98 LPAR3 (0.62) LPAR3LPAR1LPAR2S1PR2S1PR1
Phosphoric Acid Monododecyl Ester SCHEMBL8438347 0.93 LPAR3 (0.78) LPAR3LPAR1LPAR2S1PR2S1PR1
SCHEMBL28359280 0.93 LPAR3 (0.78) LPAR3LPAR1LPAR2S1PR2S1PR1
Phosphoric Acid Monododecyl Ester SCHEMBL7122511 0.93 LPAR3 (0.78) LPAR3LPAR1LPAR2S1PR2S1PR1
SCHEMBL30954787 0.93 LPAR3 (0.78) LPAR3LPAR1LPAR2S1PR2S1PR1
SCHEMBL28883677 0.93 LPAR3 (0.78) LPAR3LPAR1LPAR2S1PR2S1PR1
SCHEMBL13400489 0.92 LPAR3 (0.59) LPAR3LPAR1LPAR2S1PR2S1PR1
SCHEMBL31325188 0.89 LPAR3 (0.78) LPAR3LPAR1LPAR2S1PR2S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030083313-A1 Treatment of breast cancer with a liposome mixture comprising an antineoplastic alkylphospholipid and water- or lipid-soluble antiestrogen agents MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN (DE) 2003-05-01 US disclosed